OKYO Pharma Ltd. Form 6-K Summary
Business Context and Reporting Period
OKYO Pharma Ltd, a foreign private issuer, filed this Form 6-K on June 9, 2022. The filing reports that the company issued a UK news service announcement regarding a person discharging managerial responsibilities (PDMR) dealing.
Financial and Operating Metrics
The filing does not provide revenue, profit, cash flow, margins, debt, liquidity, or other financial metrics.
Material Changes Versus Prior Period
No financial or operating changes versus a prior comparable period are disclosed.
Guidance, Outlook, Risks, and Unusual Items
The filing contains no guidance, outlook, risk update, contingency, or unusual accounting item. The details of the PDMR transaction are referenced in Exhibit 99.1, but the exhibit text is not included in the provided filing content.
Investor Verification Points
- Review Exhibit 99.1 for the identity of the PDMR, transaction date, number and type of securities involved, transaction price, and resulting holdings.
- Confirm whether the announcement describes an acquisition, disposal, exercise, or other dealing in company securities.
- Note that the Form 6-K states the exhibit is furnished, not filed, and is not incorporated by reference into other filings unless expressly specified.